| Name | Title | Contact Details |
|---|
Far West Technology Inc is a Goleta, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HealthCube ensures that accurate diagnosis is within easy and convenient reach of billions of people in both developed and developing economies. HealthCube designs and manufactures point-of-care diagnostic devices to enhance the quality of primary care in diverse settings. HealthCube`s multiparametric technology can test for over 30 parameters including blood glucose, hemoglobin, blood pressure, detect infectious diseases markers, and even perform ECGs. Their easy-to-use and portable devices are medical grade, clinically validated, and digitally enabled, with results available instantly. HealthCube is an ISO 13485 certified company which has received certification from Central Drugs Standard Control Organization (CDSCO) and European CE. HealthCube is backed by global marquee investors including Alkemi Ventures, Perot-Jain Ventures, Acumen, and SV Latam Capital. As of date, over one million beneficiaries have been registered on HealthCube Ecosystem and 2.5 million tests have been performed.
Since 1990, Independence Medical has been one of the nation's leading wholesale medical supply distributors. Being a privately held company, we are responsive to your ever-changing needs and flexible in developing the best services for your company. You
CardioMag Imaging, Inc. (CMI) is a privately held medical device company founded in 1999 and is engaged in the development and commercialization of a unique kind of cardiac diagnostic device known as MagnetoCardioGraphs (MCG). The device the company has
Motif Neurotech is a clinical-stage company leading the development of minimally invasive neuromodulation therapeutics for mental health. The company`s lead product, for treatment resistant depression (TRD), is a miniature implant that is designed to treat TRD by increasing activity in the prefrontal cortex. Studies over 20 years show stimulation of the pre-frontal cortex effectively treats treatment resistant depression without the side effects of anti-depressants. However, existing brain stimulation treatments like transcranial magnetic stimulation (TMS) can be expensive and challenging for patients to access, with daily treatments required for six weeks that may need to be repeated. Human and large animal studies show Motif`s prototype stimulates target brain areas like TMS, and the company is preparing to begin clinical trials of their first chronic implants in 2025. Motif`s implant is enabled by patent-pending wireless magnetoelectric power transfer developed at Rice University. Motif`s founders and key team members are clinical, medical device and academic experts with over 5,000 surgical procedures and decades of medical device experience.